Dutt T, Choreno-Parra J
Front Immunol. 2025; 16:1562567.
PMID: 39995662
PMC: 11847867.
DOI: 10.3389/fimmu.2025.1562567.
Gunasekaran H, Ranganathan U, Bethunaickan R
Front Immunol. 2025; 16:1538127.
PMID: 39981231
PMC: 11839662.
DOI: 10.3389/fimmu.2025.1538127.
Musyoki V, Mureithi M, Heikinheimo A, Maleche-Obimbo E, Kithinji D, Musau S
F1000Res. 2025; 13:1543.
PMID: 39981106
PMC: 11840297.
DOI: 10.12688/f1000research.159555.1.
Arce-Aceves M, Espinosa-Neira R, Mata-Espinosa D, Barrios-Payan J, Castelan-Sanchez H, Alcaraz-Estrada S
Sci Rep. 2025; 15(1):2811.
PMID: 39843896
PMC: 11754857.
DOI: 10.1038/s41598-024-81446-3.
Della Bella C, Motisi M, Venturini E, DElios S, Asvestopoulou E, Tamborino A
Eur J Pediatr. 2025; 184(2):147.
PMID: 39831989
PMC: 11753305.
DOI: 10.1007/s00431-025-05972-6.
Downregulation of IRF7-mediated type-I interferon response by LmCen parasites is necessary for protective immunity.
Sepahpour T, Alshaweesh J, Azodi N, Singh K, Ireland D, Valanezhad F
NPJ Vaccines. 2024; 9(1):250.
PMID: 39702382
PMC: 11659581.
DOI: 10.1038/s41541-024-01032-6.
Identification of diagnostic biomarkers and molecular subtype analysis associated with m6A in Tuberculosis immunopathology using machine learning.
Ding S, Gao J, Huang C, Zhou Y, Yang Y, Cai Z
Sci Rep. 2024; 14(1):29982.
PMID: 39622968
PMC: 11612281.
DOI: 10.1038/s41598-024-81790-4.
Immunomodulatory effects of cysteamine and its potential use as a host-directed therapy for tuberculosis.
Najafi-Fard S, Farroni C, Petrone L, Altera A, Salmi A, Vanini V
Front Immunol. 2024; 15:1411827.
PMID: 39530101
PMC: 11550979.
DOI: 10.3389/fimmu.2024.1411827.
Betel Quid Use and Tuberculosis Transmission: A Neglected Focus Area for Tuberculosis Control in Low- and Middle-Income Countries.
Manghani P, Prasad N, Khatri N, Paulino-Ramirez R, Gokhale S, Islam K
Open Forum Infect Dis. 2024; 11(11):ofae577.
PMID: 39507883
PMC: 11540138.
DOI: 10.1093/ofid/ofae577.
Unveiling the multifaceted role of toll-like receptors in immunity of aquatic animals: pioneering strategies for disease management.
Ghani M, Chen J, Khosravi Z, Wu Q, Liu Y, Zhou J
Front Immunol. 2024; 15:1378111.
PMID: 39483482
PMC: 11524855.
DOI: 10.3389/fimmu.2024.1378111.
Novel RNA biomarkers improve discrimination of children with tuberculosis disease from those with non-TB pneumonia after stimulation.
Vito O, Psarras S, Syggelou A, Wright V, Amanatidou V, Newton S
Front Immunol. 2024; 15:1401647.
PMID: 39391304
PMC: 11464340.
DOI: 10.3389/fimmu.2024.1401647.
Distinct characteristics of BTLA/HVEM axis expression on Tregs and its impact on the expansion and attributes of Tregs in patients with active pulmonary tuberculosis.
Tang P, Shen X, Gao J, Zhang J, Feng Y, Zhang J
Front Cell Infect Microbiol. 2024; 14:1437207.
PMID: 39386167
PMC: 11461443.
DOI: 10.3389/fcimb.2024.1437207.
A modified BPaL regimen for tuberculosis treatment replaces linezolid with inhaled spectinamides.
Zohaib Ali M, Dutt T, MacNeill A, Walz A, Pearce C, Lam H
Elife. 2024; 13.
PMID: 39378165
PMC: 11460978.
DOI: 10.7554/eLife.96190.
Transcriptome analysis of the diseased intervertebral disc tissue in patients with spinal tuberculosis.
Xu T, Fan W, Chen C, Feng K, Sheng X, Wang H
BMC Med Genomics. 2024; 17(1):205.
PMID: 39135040
PMC: 11318271.
DOI: 10.1186/s12920-024-01981-w.
Depletion of essential mycobacterial gene glmM reduces pathogen survival and induces host-protective immune responses against tuberculosis.
Agarwal M, Bhaskar A, Singha B, Mukhopadhyay S, Pahuja I, Singh A
Commun Biol. 2024; 7(1):949.
PMID: 39107377
PMC: 11303689.
DOI: 10.1038/s42003-024-06620-9.
Surveillance of close contacts of patients with infectious tuberculosis: a prospective cohort study.
Ma Z, Duan S, Wang W, Liu R, Li S, Shang Y
Antimicrob Resist Infect Control. 2024; 13(1):59.
PMID: 38853242
PMC: 11163748.
DOI: 10.1186/s13756-024-01419-z.
Aberrant adaptive immune response underlies genetic susceptibility to tuberculosis.
Tsareva A, Shelyakin P, Shagina I, Myshkin M, Merzlyak E, Kriukova V
Front Immunol. 2024; 15:1380971.
PMID: 38799462
PMC: 11116662.
DOI: 10.3389/fimmu.2024.1380971.
An HLA-E-targeted TCR bispecific molecule redirects T cell immunity against Mycobacterium tuberculosis.
Paterson R, La Manna M, Arena De Souza V, Walker A, Gibbs-Howe D, Kulkarni R
Proc Natl Acad Sci U S A. 2024; 121(19):e2318003121.
PMID: 38691588
PMC: 11087797.
DOI: 10.1073/pnas.2318003121.
Gut microbiome, T cell subsets, and cytokine analysis identify differential biomarkers in tuberculosis.
Chai Y, Liu X, Bai G, Zhou N, Liu D, Zhang X
Front Immunol. 2024; 15:1323723.
PMID: 38650928
PMC: 11033455.
DOI: 10.3389/fimmu.2024.1323723.
Immunogenicity and protective efficacy of Ag85A and truncation of PstS1 fusion protein vaccines against tuberculosis.
Zeng L, Ma X, Qu M, Tang M, Li H, Lei C
Heliyon. 2024; 10(5):e27034.
PMID: 38463854
PMC: 10920368.
DOI: 10.1016/j.heliyon.2024.e27034.